Elanco Animal Health Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 06:50PM GMT
Erin Elizabeth Wilson Wright - Morgan Stanley, Research Division - Equity Analyst

Hello, everyone. Thank you for joining us today. My name is Erin Wright. I am Morgan Stanley's Healthcare Services and distribution analyst. I'm pleased to have Elanco CEO, Jeff Simmons with us here today. Elanco is one of those largest animal health pharmaceutical companies globally, and we're looking forward to their comments.

For important disclosures, please see the Morgan Stanley research disclosure website at [morganstanley.com/researchdisclosures]. If you have any questions, please reach out to your Morgan Stanley sales representative. And with that, thanks again, Jeff, for coming. And I will turn it over to you for some introductory remarks.

Jeffrey N. Simmons - Elanco Animal Health Incorporated - President, CEO & Director

Yes. Okay. Thanks, Erin. Thanks for all you do, and I think you've been probably the leading analyst study in this Animal Health business for a lot of years. So thank you and to Morgan Stanley as well. And I would say the same, look to our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot